Presence of Large Deletions in Kindreds with Autism  by Yu, Chang-En et al.
Am. J. Hum. Genet. 71:100–115, 2002
100
Presence of Large Deletions in Kindreds with Autism
Chang-En Yu,1,2 Geraldine Dawson,3 Jeffrey Munson,3 Ian D’Souza,1,2 Julie Osterling,3
Annette Estes,3 Anne-Louise Leutenegger,4 Pamela Flodman,7 Moyra Smith,7
Wendy H. Raskind,5 M. Anne Spence,7 William McMahon,8 Ellen M. Wijsman,4,5
and Gerard D. Schellenberg1,2,6
1Geriatrics Research Education and Clinical Center, Puget Sound Veterans Affairs Medical Center, 2Division of Gerontology and Geriatric
Medicine, Department of Medicine, 3Department of Psychology and the Center on Human Development and Disability, 4Department of
Biostatistics, 5Division of Medical Genetics, Department of Medicine, and 6Departments of Neurology and Pharmacology, University of
Washington, Seattle; 7Department of Pediatrics, University of California, Irvine; and 8Division of Child and Adolescent Psychiatry, Department
of Psychiatry, University of Utah, Salt Lake City
Autism is caused, in part, by inheritance of multiple interacting susceptibility alleles. To identify these inherited
factors, linkage analysis of multiplex families is being performed on a sample of 105 families with two or more
affected sibs. Segregation patterns of short tandem repeat polymorphic markers from four chromosomes revealed
null alleles at four marker sites in 12 families that were the result of deletions ranging in size from 5 to 1260 kb.
In one family, a deletion at marker D7S630 was complex, with two segments deleted (37 kb and 18 kb) and two
retained (2,836 bp and 38 bp). Three families had deletions at D7S517, with each family having a different deletion
(96 kb, 183 kb, and 169 kb). Another three families had deletions at D8S264, again with each family having a
different deletion, ranging in size from !5.9 kb to 1260 kb. At a fourth marker, D8S272, a 192-kb deletion was
found in five families. Unrelated subjects and additional families without autism were screened for deletions at
these four sites. Families screened included 40 families from Centre d’Etude du Polymorphisme Humaine and 28
families affected with learning disabilities. Unrelated samples were 299 elderly control subjects, 121 younger control
subjects, and 248 subjects with Alzheimer disease. The deletion allele at D8S272 was found in all populations
screened. For the other three sites, no additional deletions were identified in any of the groups without autism.
Thus, these deletions appear to be specific to autism kindreds and are potential autism-susceptibility alleles. An
alternative hypothesis is that autism-susceptibility alleles elsewhere cause the deletions detected here, possibly by
inducing errors during meiosis.
Introduction
Autism (MIM 209850) is a developmental disorder that
is recognized in early childhood and persists throughout
life. The disorder is characterized by deficits in reciprocal
social interaction and in verbal and nonverbal com-
munication and by a restricted stereotyped range of in-
terests and activities. Autism spectrum disorders (ASD)
include autism, as the most classic form, and pervasive
developmental disorder not otherwise specified (PDD),
Asperger syndrome, and childhood disintegrative dis-
order, as closely related syndromes. Whether ASD rep-
resents a continuum of a single disorder or a mixture of
clinically related syndromes is unknown.
Autism as a complex of symptoms can occur at el-
evated rates in individuals with fragile-X syndrome
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(FMR1 [MIM 309550]), tuberous sclerosis (TS
[MIM 191100]), Prader-Willi syndrome (PWS [MIM
176270]), Angelman syndrome (AS [MIM 105830]),
and other rare disorders. Duplication of the Prader-Wil-
li region at 15q11-13 is also associated with autism
(Gillberg et al. 1991; Robinson et al. 1993; Baker et al.
1994; Cook et al. 1997b). Numerous other case reports
of autism associated with cytogenetic abnormalities
have appeared with no apparent clustering of the chro-
mosomal regions involved. However, most individuals
with ASD do not have one of these known medical
disorders or a chromosomal abnormality. For these
cases, the etiology of ASD is unknown.
Inheritance contributes substantially to ASD suscep-
tibility. MZ twins are 60% concordant for autism and
as much as 95% concordant for less-severe ASD symp-
toms related to autism (Bailey et al. 1995). The high—
but not 100%—concordance rate forMZ twins (Folstein
and Rutter 1977a, 1977b; Ritvo et al. 1985; Steffenburg
et al. 1989; Le Couteur et al. 1996) indicates that genetic
factors are a major contributor to ASD susceptibility but
also that environmental factors contribute to risk. DZ
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Figure 1 Family AU018 genotypes for D7S630 and flanking
polymorphic markers. Genetic markers are listed next to genotypes
for subject AU01801. Markers are listed in their physical order (fig.
2). Null alleles are shown as dashed lines.
twins and siblings have much lower concordance rates
(3%–4.5%) (Bolton et al. 1994), indicating that the ge-
netic basis of ASD is complex and that presumably mul-
tiple genes contribute in an interactive manner to confer
ASD susceptibility. Estimates of the number of genes
range from 2–10 (Pickles et al. 1995) to 15 (Risch et
al. 1999; Pritchard 2001), and the exact number of genes
and the mode of inheritance are unknown.
Genomewide linkage analysis studies of families with
autism have yielded positive signals for chromosomes
1, 2q, 7q, 9, 13, 15, and 16p (Barrett et al. 1999; Phi-
lippe et al. 1999; Risch et al. 1999; Buxbaum et al.
2001; Liu et al. 2001; IMGSAC 2001a), though no
region has been unambiguously confirmed in all studies.
The best candidates for regions containing an autism
locus are chromosomes 2q and 7q (Barrett et al. 1999;
Philippe et al. 1999; IMGSAC 2001a, 2001b; Buxbaum
et al. 2001). Specific genes have been tested as candidate
autism-susceptibility loci, selected for any of four rea-
sons:
1. Biological plausibility—for example, HOXA1 (MIM
142955), HOXB1 (MIM 142968) (Ingram et al. 2000),
EN-2 (MIM 131310) (Petit et al. 1995), and the sero-
tonin transporter SLC6A4 (MIM 182138) (Cook et al.
1997a).
2. Location in a region with a positive linkage sig-
nal—for example, reelin (RELN (MIM 600514) (Persico
et al. 2001), WNT2 (MIM 147870) (Wassink et al.
2001), and VIPR2 (MIM 601970) (Asano et al. 2001).
3. Disruption by a translocation in a subject with au-
tism—for example, RAY1 (MIM 600833) (Vincent et al.
2000).
4. Location in the PWS-AS deletion region—for ex-
ample, the GABA receptor (GABRB3 [MIM 137192])
(Cook et al. 1998).
However, no gene has been conclusively identified as an
autism-susceptibility locus.
In the course of performing a genome scan for autism-
susceptibility genes, we identified four interstitial dele-
tions in individuals from 12 families that had two or
more siblings with autism. One of these deletions, ini-
tially detected with marker D8S272, is 192 kb and is
also found in control samples. Thus, this is an insertion/
deletion (in/del) polymorphism with a very-large-dele-
tion allele. For the remaining three sites, deletion alleles,
ranging in size from !5.9 kb to 1250 kb, were detected
only in multiplex families with autism. These deletions
did not segregate perfectly with the disease in each case.
Thus these deletions may not be causative, but rather
suggest that autism is the result of a genetic predispo-
sition to errors in meiosis.
Subjects, Material, and Methods
Characterization of Families with Autism and
Diagnostic Criteria
Families who identified themselves as having two or
more children with autistic disorder and/or PDD, were
recruited through the National Institutes of Health Col-
laborative Programs of Excellence in Autism, a network
of sites at the University of Washington (98 families),
the University of California at Irvine (families AUO17,
AUO27, and AUO39), and the University of Utah (4
families). The University of Washington recruitment net-
work included testing sites in Washington, Oregon, Flor-
ida, Tennessee, Arizona, Minnesota, and Texas. When
possible, a blood sample was obtained from both par-
ents, each affected sibling, and an unaffected sibling. At
least one parent was available from each family. Exclu-
sionary criteria included an age !3 years, the presence
of a known genetic condition—for example, neurofi-
bromatosis (NF1 [MIM 162200]), TS, phenylketonuria
(PKU [MIM 261600]), FMR1, William-Beuren syn-
drome (WBS [MIM194050]), or velocardiofacial syn-
drome (VCFS [MIM 192430])—or a serious head injury.
All affected individuals were administered a diagnostic
evaluation consisting of the Autism Diagnostic Inter-
view—Revised (ADI-R) (Lord et al. 1994) and the Autism
Diagnostic Observation Schedule—Generic (ADOS-G).
Both instruments assess the symptoms of PDD, including
autism, as defined in DSM-IV (American Psychiatric As-
sociation 1994). In addition, a clinical diagnosiswasmade
by the clinician evaluating the child, on the basis of the
presence or absence of DSM-IV symptoms of autism. All
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Figure 2 Physical map of D7S630 region and structure of the deletion allele. Locations of deletion boundaries are given on the top genomic
contig line as positions in NT_017168.5 (accession number GI:15298273). Arrows labeled PFB1 and PRB1 indicate the location of primers used
to amplify del-D7S630. Arrows labeled PFA1 and PRA1 indicate the location of primers used to amplify del-D7S630-A (table 1 and fig. 3D).
Genetic markers, with locations in NT_017168.5 given in parentheses, are as follows: 1, 2127-CT (3534931); 2, 2127-CA1 (3484630); 3,
2127-GT (3466041); 4, 2127-ATCT (3457424); 5, D7S630 (3452308); 6, 4746-TET (3412376); 7, 4746-CA (3398684); 8, rs1016807(3370218);
and 9, 4746-GT (3324233). GenScan-predicted genes are shown as unblackened arrows, and an EST-predicted gene is shown as a blackened
arrow.
children were administered a standardized intellectual
evaluation appropriate for their age level (Mullen Scales
of Early Learning or Weschler Scales of Intelligence, short
form).
Diagnosis of autism was defined as meeting criteria for
autism on the ADOS-G and ADI-R and clinical diagnosis.
In addition, if a child received a diagnosis of autism on
the ADOS-G and clinical diagnosis, and came within 2
points of meeting criteria on the ADI-R, the child was
also considered to have autism. Diagnosis of PDD case
type 1 was defined as meeting criteria for PDD on the
ADOS-G, meeting criteria for autism on the ADI-R or
missing criteria on the ADI-R by 2 points, and meeting
criteria for PDD or autism on the basis of clinical diag-
nosis. Diagnosis of PDD case type 2 (PDD2) was defined
as meeting criteria for PDD on the basis of clinical di-
agnosis but failing to meet criteria for PDD on the ADOS-
G and/or ADI-R. Individuals who had clinical features of
ASD (e.g., clinically significant language and/or social im-
pairment, according to the ADI-R and ADOS-G) but
whose symptoms were not numerous or severe enough to
receive a clinical diagnosis of autism or PDDwere referred
to as “broader phenotype.” The studies described here
were approved by the University of Washington institu-
tional review board, and appropriate informed consent
was obtained from all subjects.
Genetic Markers
For the initial genome screen, STRPmarkers were from
the ABI Prism linkage mapping set, version 2, spaced at
∼10 cM. Chromosome 7markers were D7S531, D7S517,
D7S513, D7S507, D7S493, D7S516, D7S484, D7S510,
D7S519, D7S502, D7S669, D7S630, D7S657, D7S515,
D7S486, D7S530, D7S640, D7S684, D7S661, D7S636,
D7S798, and D7S2465. Other chromosome 7 markers
genotyped were D7S2500, D7S1813, and D8S645, which
are between D7S502 and D7S669. Chromosome 8 mark-
ers were D8S264, D8S277, D8S550, D8S549, D8S258,
D8S1771, D8S505, D8S285, D8S260, D8S270,
D8S1784, D8S514, D8S284, and D8S272. Chromosome
15 markers were D15S128, D15S1002, D15S165,
D15S1007, D15S1012, D15S994, D15S978, D15S117,
D15S153, D15S131, D15S205, D15S127, D15S130, and
D15S120. Chromosome 16 markers were D16S423,
D16S404, D16S3075, D16S500, D16S3046, D16S3068,
D16S3136, D16S415, D16S503, D16S515, D16S516,
D16S3091, and D16S520. SNP markers were from an-
notations of genomic sequence contigs found in Gen-
Bank; the designations for these loci begin with “rs”
(e.g., rs1016807 is an SNP found in the annotation for
contig NT_017168.5) (see figs. 1 and 2). New STRP loci
were identified by searching genomic sequences for di-,
tri-, and tetranucleotide repeat tracks. These loci are des-
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Table 1
PCR Primers Used to Genotype Deletion Alleles
Locus Primer/Contig
Primer Sequence
(5′r3′)
Product Size
(bp)a
Location
in Contig
D7S630/NT_017168.5:
2127-LG2-F AGATCCCCATGACTATGTTTAGTACAGGG 3466226
2127-LG4-F CATTGAGGGTAGAACTGAAACCATGGG 3462955
4746-LG1-R AGTATAACCAGCAGTTAACAATTGAGGG 3398803
4746-LG2-R ATACCTCCATCATTATTCCTAGGCTGG 3404326
PFA1 ATCTACAAAGGGGTGACTTTAGG 400 3404174
PRA1 AAATGAAGACAATGTCAAACTTATTG 3422995
PFB1 GGCCAAATTATGTGCTATACAAGG 161 3425643
PRB1 GTCAGCTTCTATACAGAGATTTGG 3462342
D7S517/NT_007784.5:
PFA2 CCCAAAACTCGGAAACGTGAAG 374 122158
PRA2 AGTTTGGCACAGCCCATATAGG 25811
PFB2 CCTAGCTGCATAAAAACTCCTGG 1687 219891
PRB2 GGACTGCGTGGAAGAGCTGG 35217
D8S272/NT_008104.5:
PFA3 GTGTAGTGGAGCCACTATGCTC 181 1086974
PRA3 GATCAAGGGATGATGAGTATCTC 1269241
NOTE.—Primer sequences for genotyping STRP and SNP loci are available in the online-only appendix.
a Product sizes are for amplification of the deletion allele. For the nondeletion allele, no product is
amplified.
ignated with a number followed by the repeated nucle-
otides (e.g., 2127-CT is a dinucleotide CT-repeat poly-
morphism) (fig. 1).
Genotype Analysis
For genotyping, DNA samples from families with au-
tism were extracted from blood. Genotypes were deter-
mined by PCR amplification of polymorphic loci, per-
formed with primers labeled with fluorescent probes.
DNA fragments were resolved by use of an ABI 377
DNA sequencer. The computer program Loki was used
to identify genotypes incompatible with Mendelian in-
heritance. SNPs were genotyped by single-nucleotide ex-
tension assays performed with SnapShot reagents (PE
Biosystems), and the resulting products were analyzed
by use of an ABI 377 Sequencer. Primers used to assay
specific deletions alleles are given in table 1. Primer se-
quences used for SNPs, STRP loci, and DNA sequencing
are in the online-only appendix.
Long-Range PCR Amplification.
DNA fragments spanning deletion junctions were am-
plified by use of long-range PCR. Amplification was per-
formed by use of the Takara LA Taq DNA Polymerase
Kit (Takara Shuzo), with primers at 0.2 mM each and
200 ng of template genomic DNA in a final volume of
50 ml. PCR profile consists of 1 cycle for 1 min at 94C,
30 cycles for 20 s at 98C, and 10 min at 68C, and a
final extension at 72C for 10 min. The amplified prod-
ucts were analyzed by agarose gel electrophoresis, and
fragments were visualized by use of ethidium bromide.
DNA Sequence Analysis
For DNA-sequence analysis, PCRs were carried out by
mixing 20 pmol of primers and 40 ng of genomic DNA
with HotStarTaq DNA Polymerase master mixture (Qia-
gen) in a final volume of 20-ml reactions. After 30 cycles,
2 ml of ExoSAP-IT (USB) was added to the PCR products
and was digested for 1 h to remove the residual primers
and dNTPs. For sequencing of long-range PCR products,
fragments were purified by agarose gel electrophoresis,
and bands were recovered by use of the Gel Band Puri-
fication Kit (Amersham Pharmacia Biotech). Sequencing
reactions were performed with the BigDye Terminator
cycle sequencing kit, using 4 ml of the processed PCR
fragments in a final volume of 10 ml. Fragments were
resolved using an ABI 377 DNA sequencer. Repeat se-
quences were identified by use of the RepeatMaster (ver-
sion 4/4/2000), ProcessRepeats (version 4/4/2000), and
Repbase (version 3/31/200), and the results were inte-
grated by use of the Seqhelp search interface.
Generation of Somatic Cell Hybrids
GM459A cells—an HPRT-negative Chinese hamster
ovary (CHO) cell line—were maintained in Dulbecco’s
modified Eagle medium (DMEM) supplemented with
10% fetal bovine serum (FBS) (Gibco). A lymphoblas-
toid cell line (LCL) from family AU018, subject
AU01803, was maintained in Roswell Park Memorial
Institute (RPMI) medium supplemented with 10% FBS
(Gibco). GM459A cells were seeded at a concentration
of 107 cells per 100-mm tissue-culture dish. After 24 h,
cells were washed with DMEM without serum, and 5
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Table 2
Families with Autism
Diagnosis of Sibs
No. of
Families
Autism/autism 44
Autism/PDD 22
Autism/PDD2 18
Autism/BPH 7
PDD/PDD 3
PDD/PDD2 6
PDD/BPH 4
PDD2/PDD2 1
Total 105
NOTE.—The average age of affected subjects at
assessment is 8.95 years (SDp 4.76 years). The eth-
nicity is predominantly (84%) white. The mean full-
scale IQ values for affected subjects, unaffected sibs,
and parents are 74.9 (SD p 26.6), 107.9 (SD p
16.2), and 113.5 (SD p 13.0), respectively.
# 107 LCLs were added in 5 ml of DMEM without
serum containing 125 ml of a 1 mg/ml stock of phy-
tohemagglutin-P (Sigma). Dishes were incubated at 37C
for 15 min. The media were gently aspirated, and 2 ml
of 50% polyethylene glycol (1,000 MW) (Sigma) was
layered over each dish. After treatment for 1 min, cells
were washed three times with DMEM and were incu-
bated in 10 ml of serum-free DMEM at 37C for 30
min. Cells were allowed to recover overnight in 10 ml
DMEM, 10% FBS. The next day cells from each 100-
mm dish were trypsinized and seeded 1:5 into fresh 100-
mm dishes containing selection media composed of
DMEM with 20% FBS and a 1# solution of hypoxan-
thine-aminopterin-thymidine (HAT) (Sigma). Cells were
fed fresh selection media every 2–3 d. After 2–3 wk,
individual colonies were transferred to a 16-mm well
(24-well plate) and were expanded in duplicate 35-mm
wells (6-well plates). One well was used for genomic
DNA isolation and genotyping, while the other was used
for further expansion and freezing of the clone. Clones
were maintained in HAT selection media throughout the
experiment.
Results
Families with two or more subjects affected with autism,
PDD (case types 1 and 2), or broader-phenotype autism
were identified for use in genetic linkage studies (table
2). Chromosomes 7 and 15 were initially targeted be-
cause previous studies indicated the presence of autism
loci on these chromosomes (Barrett et al. 1999; Philippe
et al. 1999). Chromosomes 8 and 16 were also analyzed
as part of accompanying marker panels to be used in a
complete genome screen. Genotypes for 66 dinucleotide
STRP markers spaced at ∼10-cM intervals across these
four chromosomes were checked for compatibility with
reported family relationships. Apparent non-Mendelian
inheritance was observed for six markers (D7S630,
D7S517, D8S264, D8S272, D8S258, and D8S1784) in
18 families (table 3 and fig. 1). In these families, one or
more children were homozygous and failed to inherit an
allele from a homozygous parent. The incompatible ge-
notypes could not be explained by mutations adding or
deleting a single dinucleotide repeat unit (Weber and
Wong 1993). These same families did not exhibit in-
compatible genotypes with other markers, thus elimi-
nating inaccurate paternity information and sampling
errors as the source of incompatibilities. The discrep-
ancies in the families could be rectified if the incompat-
ible parent-child pairs were assumed to have a null allele.
Because the rate of apparently null alleles appeared
higher than in our other studies, we determined the cause
of these null-allele phenotypes.
Null alleles can result from failure to amplify an allele
caused by a polymorphic base in the sequence corre-
sponding to the primers used to amplify the locus, a
common source of genotype errors (Ewen et al. 2000).
Therefore, for the six sites with potential null alleles,
new primers were designed that were either both inter-
nal or both external to the original primer pairs. For
D8S258 and D8S1784, previously unobserved alleles
amplified with the new primers resulting in genotypes
compatible with the family structures. However, for the
remaining four loci, the incompatibilities were not re-
solved. These four loci were characterized as follows.
D7S630 Deletion
To characterize the D7S630 null allele, SNP and STRP
loci flanking D7S630 were genotyped in family AU018
(figs. 1 and 2). For the two flanking STRP sites 4746-
tet and 2127-ATCT, non-Mendelian inheritance com-
patible with a null allele was observed (fig. 1). These
results are compatible with a deletion with a minimum
size of 45.2 kb (fig. 2). In contrast, genotypes for the
more distantly flanking STRP sites 2127-GT and 4746-
CA were compatible with the family structure, defining
a maximum deleted region of 67.3 kb.
The deletion allele was characterized by initially de-
signing four PCR primer pairs flanking the obligate de-
leted segment. These primerswere used in long-rangePCR
experiments to amplify across the junctions of the dele-
tion, using DNA from deletion carrier AU01804. The
nondeleted allele was not amplified because the distance
between the primers was too great. Three different primer
pairs produced fragments that were ∼9, ∼6.9, and ∼3.7
kb in size (fig. 3A). The 3.7-kb fragment could be am-
plified from family AU018 subjects predicted to have the
null allele but not from family members heterozygous for
D7S630 or from unaffected control subjects (fig. 3B). This
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Table 3
Deletions in Families with Autism
MARKER
AND FAMILY
SEX OF PARENT
WITH DELETION
NO. OF SIBS (DIAGNOSIS)
DELETION SIZE
(kb)With a Deletion Without a Deletion
D7S630:
AU018 Male 2 (PDD) 1 (unaffected) 57
D7S517:
AU026 Female 1 (autism), 1 (PDD2) 1 (unaffected) 169
AU044 Male 2 (autism), 1 (unaffected) 0 183
AU098 Male 1 (autism) 1 (autism) 96
D8S264:
AU025 Female 0 2 (autism) !5.9
AU058 Female 2 (autism) 0 260–283a
AU113 Female 1 (autism) 1 (PDD2), 1 (unaffected) 252–266a
D8S272:
AU002 Male 1 (autism), 1 (unaffected) 1 (autism) 192
AU085 Female 3 (PDD2) 0 192
AU141 Female 2 (autism) 0 192
AU142 Female 1 (autism), 1 (PDD2) 0 192
UO2 Female 2 (autism), 2 (unaffected) 1 (unaffected) 192
NOTE.—Deletions were initially detected in DNA samples isolated directly from blood.
a Sizes may not be correct, because of potential errors in the genomic DNA contig covering this region.
3.7-kb fragment was sequenced to define the breakpoints
of the deletion. The structure of the deleted allele is com-
plex. Three segments (36.5 kb, 18 kb, and 273 bp) are
missing, and two segments (2,836 bp and 37 bp) are
retained. The orientation of the shorter retained seg-
ment is reversed from its normal orientation (fig. 2).
Thus the null allele in family AU018 is a 54,925-bp
complex deletion.
To confirm the presence and structure of the deletion,
cells from deletion-carrier AU01803 were fused with
CHO cells to obtain somatic-cell hybrid lines that con-
tain a single human chromosome 7. Two lines were ob-
tained, 1 with the deletion allele chromosome 7 and the
second with the nondeletion allele chromosome 7. DNA
from the hybrids was genotyped for sequence-tagged
sites (STSs) located within and flanking the deletion. The
STS content of each line was compatible with the pre-
dicted deletion (fig. 3C).
No known gene, EST, or GenScan-predicted genes
were in the deletion. There is a cluster of EST sites im-
mediately upstream of the deletion (fig. 2). Although
these ESTs matched the genomic sequence, there was
no evidence of intron-exon splicing, and this region was
not part of a GenScan-predicted gene. A gene was pre-
dicted by GenScan, immediately downstream of the de-
letion that did not match any known genes or ESTs.
To facilitate large-population screening for the
D7S630 deletion, primer sets PFA1/PRA1 and PFB1/PRB1 (ta-
ble 1) were designed to separately amplify the segment
of the deletion allele missing del-D7S630A and the seg-
ment missing del-D7S630B, respectively (fig. 2). The
PCR products were 400 bp and 161 bp, corresponding
to alleles missing 18 kb and 36.5 kb, respectively (fig.
3D). The same primers did not produce a product from
the nondeletion allele.
D7S517 Deletion
Characterization of the D7S517 null alleles was per-
formed by the same approach as used for the D7S630
deletion. Six STRP and 21 SNP sites flanking D7S517
were genotyped in the three families showing a D7S517
null allele. While not all sites were informative, the re-
sults indicated that each family had a different deletion
(fig. 4 and table 3). For families AU044 and AU098, the
deletions were entirely within genomic contig Celera-1R.
For family AU026, the deletion extended past the end
of the available sequence. Marker genotypes from the
next contig (NT_007747) were compatible with the
known family structure for AU026. Thus, one end of
this deletion was not present in available genomic se-
quence. The three deletions have a 24-kb region in com-
mon that contains D7S517 (fig. 4). Three GenScan-pre-
dicted genes were in the deletion region, but only one
was missing in all three types of deletions. These pre-
dicted genes did not match known genes or ESTs.
The DNA sequences for the deletion junctions for
families AU044 and AU098 were determined as de-
scribed above for D7S630. Primer sets PFA2/PRA2 and
PFB2/PRB2, which flank the deletion junctions, produced
1.7-kb and 374-bp PCR products from null-allele sub-
jects from families AU044 and AU098, respectively (fig.
5). These fragments were sequenced to identify the de-
letion junctions.
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Figure 3 Long-range PCR amplification of the D7S630 deletion allele. Genomic DNA samples are from the AU018 family (fig. 1) or
unrelated unaffected control subjects (NCO samples). Amplified fragments were resolved by use of agarose gel electrophoresis and were detected
with ethidium bromide staining. A, Long-range PCR performed to identify primer pairs that can amplify across the D7S630 deletion-allele
junction. Primer combinations were as follows: 1, 2127-LG2-F and 4746-LG1-R; 2, 2127-LG2-F and 4746-LG2-R; 3, 2127-LG4-F and 4746-
LG1-R; and 4, 2127-LG4-F and 4746-LG2-R (table 1). B, Primer pair D (2127-LG4-F and 4746-LG2-R) was used to assay for the D7S630
deletion allele in the entire AU018 family and in unaffected control subjects NCO16 and NCO25. C, Genetic markers were used as STSs in
an unaffected control subject NCO087, in subject AU01803, who has the AU018 deletion allele, and in a CHO-AU01803 hybrid containing
a single copy of human chromosome 7 that has the D7S630 deletion allele.D, Deleted segments del-D7S630-A and del-D7S630-B were amplified
in a single PCR reaction, using primer pairs PFA1/PRA1 and PFB1/PRB1, respectively (table 1 and fig. 2). This combination of primer pairs was used
to directly screen for the D7S630 complex deletion (table 4).
D8S272 Deletion
To characterize theD8S272 deletion, 11 STRP and SNP
sites were genotyped in the five autism kindreds with null
alleles at this site (fig. 6). The results were compatible
with a deletion of minimum and maximum sizes of 157.1
kb and 207.2 kb, respectively. Long-range PCR was per-
formed with primer pairs flanking the deletion site, using
DNA from subjects with a D8S272 null allele. One primer
set produced a 1.7-kb fragment in subjects with the null
allele but no product in subjects without a null allele.
Sequence from this junction fragment indicates the dele-
tion allele is missing 192 kb. For all five families with this
deletion, identical-sized fragments were produced when
the deletion allele was amplified by use of the flanking
primers. Thus the deletion appears to be identical in each
family. To facilitate screening for this mutation, a second
primer pair (PFA3/PRA3) was designed to produce a 181-bp
product spanning the deletion (fig. 7).
There were three GenScan predicted genes in the de-
letion region. The flanking two predicted genes did not
match known genes or ESTs. The center predicted gene
that is completely deleted matched an EST from a random
activation of gene expression (RAGE) library (Harrington
et al. 2001). Comparison of the EST sequence to the ge-
nomic sequence indicates the EST sequence is compatible
with intron removal by RNA splicing (fig. 6).
D8S264 Deletion
To characterize theD8S264 deletion, 65 STRP and SNP
sites flankingD8S264were genotyped in the three families
with null alleles at this locus. Genotype results for some
of these markers are shown in table 4 and locations for
a subset of markers is shown in figure 8. Annotation of
genomic contig NT_008087.5 for this region indicates
that the sequence assembly may contain errors due to
repeated sequences (fig. 8). Thus, the marker order for
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Figure 4 D7S517 genomic structure and deletion alleles. Deletion boundary positions listed above the top line (genomic contig) are based
on numbering from contig NT_007784.5 (accession number GI:15299808). Arrows PFA2 and PRA2 show primer locations for amplifying del-
D7S517A. Arrows PFB2 and PRB2 show primer locations for amplifying del-D7S517B. Genetic markers with locations in NT_007784.5 given in
parentheses are as follows: 1, rs975926 (4421); 2, CE1R-AGGG (8891); 3, CE1R-CA (29444); 4, 16898-AT (53633); 5, D7S517 (74190); 6,
CE1R-AGAT (93628); 7, CE1R-GT (115042); 8, D7S472 (132296); 9, rs730813 (195200); and 10, rs2005745 (219539). Genes predicted by
GenScan are shown as large unblackened arrows.
site 1–9 in figure 8 may be incorrect. When these poly-
morphic markers were genotyped in the three families
with null alleles at D8S264, different patterns emerged
for each family. For all three families, the deletion alleles
appear to end at approximately the same site, defined by
marker 11 in fig. 8. In each of the three families, at least
one subject with a D8S264 null allele was heterozygous
at SNP 11. Genotype patterns indicated that the other
ends of the deletions were different in each family. For
family AU025, marker 9 in figure 8 was also heterozy-
gous in the parent and child with the null allele. The on-
ly marker showing a null allele in family AU025 was
D8S264. Thus, the deletion in this family is !5.9 kb, and
it may be considerably smaller. For family AU058, mark-
er 2 in figure 8 was consistent with a null allele, whereas
marker 1 was heterozygous and thus is outside the delet-
ed region. The minimum and maximum sizes for this
deletion are 260 and 283 kb, respectively. Family AU113
has a somewhat smaller deletion defined by markers 2
and 3 with a size range of ∼252–266 kb (fig. 8). Of the
markers shown, all except site 5 were consistent with the
deletion pattern shown in fig. 8. Marker 5 was hetero-
zygous in the AU058 family parent who had the null
allele. This inconsistency suggests that the contig assembly
(as indicated by the GenBank annotation) is incorrect or
that these deletions are complex, as was observed with
D7S630. Because the genomic sequence was not reliable,
we were unable to identify and clone fragments spanning
these deletions.
Six GenScan-predicted genes were in the region cov-
ered by the deletions. Two are in the region potentially
deleted in all three families. One of the predicted genes
was homologous to a single EST that showed evidence
of splicing (fig. 8). The closest known gene is the en-
dosarcomeric cytoskeletal M-protein gene (MYOM2
[MIM 603509]).
Deletion Alleles in Subjects Not Affected with Autism
To determine whether the deletions observed are spe-
cific to families with autism, families affected with learn-
ing disability (LD) and families from CEPH were ge-
notyped for D7S630, D7S517, D8S264, and D8S272 to
detect null alleles. The families from CEPH consisted of
40 families with two or three generations sampled and
253 founder chromosomes. Founder chromosomes are
defined as independent chromosomes that could poten-
tially contribute a deletion allele. The families with LD
were 28 kindreds sampled for 2–4 generations with
164–194 founder chromosomes sampled (depending on
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Figure 5 Amplification of D7S517 deletion alleles. Deletion alleles were amplified with primer pairs PFA2/PRA2 and PFB2/PRB2 for del-D7S517A
and D7S517B, respectively (table 1 and fig. 4). PCR products were resolved by agarose gel electrophoresis and were stained with ethidium
bromide. Samples used and family structures are shown at the top.
the marker used). These samples are comparable to the
families with autism, which had 388 founder chromo-
somes sampled. No null alleles were detected in the
CEPH and LD families for markers D7S630, D7S517,
or D8S264. For D8S272, one family with LD and one
family from CEPH (Z1416) had genotypes consistent
with a D8S272 deletion allele.
Deletion Alleles in Unrelated Subjects
Because the D7S630, del-D7S517A, del-D7S517B,
and D8S272 deletion alleles can be directly detect-
ed (figs. 3, 5, and 7), control populations were screened
for these alleles (table 4). In addition, the CEPH fam-
ily founders, were directly assayed for the deletion al-
leles, as were the autism family members. These families
were rescreened, because, in some families, null alleles
could be missed if genotypes were uninformative. Un-
related adult control subjects were also screened for
these deletion alleles. A cohort of subjects with late-on-
set Alzheimer disease (LOAD [MIM 104300]) and age-
matched control subjects were screened as representative
of another neurologic disease, to determine specificity of
the deletion alleles. Because the D7S630 deletion was
complex, primer pairs were used that amplify indepen-
dently across the two deleted segments (fig. 3D). For
D7S630, del-D7S517A, and del-D7S517B, no examples
of deletion alleles were observed in subjects fromCEPH,
elderly control subjects, younger control subjects, or sub-
jects with LOAD. In contrast, for D8S272, deletion al-
leles were detected in all the non-autism groups tested
(table 4). To detect potential D8S272-deletion homo-
zygotes, samples with deletions were also genotyped for
D8S272. An appropriately sized fragment was observed
in all subjects with a deletion, from all samples used,
indicating that none were homozygous for the deletion
allele.
The deletion allele frequencies in subjects with autism
were compared to the deletion allele frequencies in control
subjects for each of the four deletion sites. Values from
the autism sample were compared to each individual con-
trol group (LD, CEPH, elderly control subjects, young-
er control subjects, and subjects with LOAD) and to all
control subjects for whom data were available pooled as
one group. (Note that the deletion allele frequencies for
D7S517, D7S630, and D8S264 were 0 for all control
groups tested [table 4].) Contingency-table analysis was
carried out with a Fisher exact test, estimated by Mar-
kov chain–Monte Carlo methods (Guo and Thompson
1992). For D7S630, D7S517, or D8S264, when the fre-
quencies from the autism sample were compared with
those of each control subject or those of the pooled con-
trol subjects, there was no significant difference. How-
ever, for D8S272, the difference between the autism group
and the individual control groups or the pooled control
subjects was highly significant ( andP ! .0001 Pp
, respectively), with the deletion allele being less.0018
common in the subjects with autism, compared with con-
trol subjects, except for the LD group. There were also
differences among control groups. The healthy control
subjects, who were young, were different ( )P ! .0001
from the elderly control subjects and subjects with LOAD
(table 4). Also, the subjects from CEPH were different
from the elderly control subjects and subjects with LOAD
but not the younger control group. The autism sample
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Figure 6 D8S272 region genomic structure and deletion alleles. Deletion-boundary positions given beneath the top line (genomic contig)
are from contig NT_008104.5 (accession number GI:15300207). Arrows mark the location of primers PFA3 and PRA3 that were used to directly
amplify the deletion allele (fig. 7). Genetic markers with locations in NT_008104.5 given in parentheses are as follows: 1, 26261-CT (1044194);
2, 8104-CCCT (1082018); 3, 8104-TG (1084178); 4, 13646-GTT (1138446); 5, 13646-CTTT (1155366); 6, 13646-ATTT (1193790); 7,
D8S272 (1214065); 8, 13646-TA (1235221); 9, 13707-ATCT (1249914); 10, 13707-AAAT (1267145); 11, 12410-GT (1373533); and 12,
12410-CA (1410210). Genes predicted by GenScan are shown as large unblackened arrows.
Figure 7 Amplification of the D7S272 deletion allele. Samples
are from families with autismAU002 (left) andAU141 (right).Deletion
alleles were amplified with primer pair PFA3/PRA3. PCR products were
resolved by agarose gel electrophoresis and were stained with ethidium
bromide. Samples used and family structures are shown at the top.
Subjects showing a 181-bp PCR product were heterozygous for the
D7S272 deletion allele and subjects showing no product were ho-
mozygous for the nondeletion long allele.
differs from both the young ( ) and the elderlyP ! .0001
control subjects ( ). In light of the significant re-Pp .04
sults for D8S272, stratified exact contingency-table anal-
ysis was performed using either the three nonpolymorphic
deletions (D7S630, D7S517, and D8S264) or all four de-
letion sites (D8S272) together. For both the three- and
the four-marker analyses, there was a significant differ-
ence between the autism sample and the pooled control
sample ( ).P ! .0001
Discussion
In the process of performing genetic linkage studies of
autism, we identified, in 12 of 105 families, large-de-
letion alleles at four different sites on chromosomes 7
and 8. For three of these sites (D7S630, D7S517, and
D7S264), deletion alleles were found in kindreds with
autism but not in families with LD or in other control
populations. For these three sites, each family with a
deletion allele had a different segment deleted. For a
fourth site, at D8S272, the deletion allele identified in
families with autism was also observed in subjects not
affected with autism, including healthy control subjects.
For this site, each example of the deletion appeared to
be identical.
Because deletions at D7S630, D7S517, and D8S264
were observed only in families with autism or PDD and
not in control families (table 4), these deletions are po-
tentially involved in genetic susceptibility to autism.
However, interpretation of the results presented here is
complicated by the fact that the characteristics of au-
tism-susceptibility alleles are difficult to predict because
the mode of inheritance for the disorder is unknown.
The difference between concordance rates forMZ twins
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Table 4
Frequency of Deletions in Different Populations
MARKER
DELETION ALLELE FREQUENCIES (CHROMOSOMES WITH DELETION/TOTAL CHROMOSOMES SAMPLED)a
Autism Learning Disability CEPH
Younger Control
Subjectsb
Elderly Control
Subjectsc LOAD
D7S630 .003 (1/388) .0 (0/164) .0 (0/238) .0 (0/188) .0 (0/574) .0 (0/474)
D7S517 .008 (3/388) .0 (0/192) .0 (0/253) NA NA NA
del-D7S517A .003 (1/388) ND ND .0 (0/242) .0 (0/504) .0 (0/396)
del-D7S517B .003 (1/388) ND ND .0 (0/180) .0 (0/498) .0 (0/374)
del-D7S517C .003 (1/388) ND ND NA NA NA
D8S264 .008 (3/388) .0 (0/191) .0 (0/270) ND ND ND
D8S272 .013 (5/388) .005 (1/192)d .104 (25/241) .082 (14/170) .035 (21/598) .026 (13/494)
NOTE.—ND p not determined. NA p not applicable. It is not possible to screen directly for del-D7S517C by a PCR assay. Therefore, the
complete set of D7S517 deletions can be examined only by segregation of the D7S517 STRP in families with one or both parents sampled.
a Autism, CEPH, and LD groups were initially screened for null alleles by examination of segregation patterns of marker genotypes in the
families. All subjects in the families with autism were screened for deletions D7S630, del-D7S517A, del-D7S517B, and D8S272, by use of the
direct assays described in figures 3, 5, and 7. These same deletion assays were used to screen the CEPH grandparents (in three-generation
families) or parents (in two-generation families), and the control and LOAD populations, but not the families with LD. For the autism sample,
the younger control subjects, elderly control subjects, and subjects with LOAD, the DNA samples were isolated directly from blood. For the
subjects with LD, most of the DNA samples were isolated directly from blood with the rest from lymphoblastoid cell lines. All CEPH DNA
samples were drawn from lymphoblastoid cell lines.
b Younger control subjects were laboratory workers and subjects recruited by an advertisement for control subjects. The mean age was 36.9
years (SD p 12.7).
c Elderly control subjects were spouses and caregivers of subjects with dementia who were seen by the University of Washington Alzheimer’s
Disease Research Center. The mean age at the time of sampling was 73.5 years (SDp 8.56). Subjects with LOAD seen at the same clinic had
a mean age at sampling of 73.3 years (SD p 9.34).
d The families with LD were screened for the deletions only by use of segregation analysis of marker genotypes. The direct PCR assays for
the deletions were not performed on these families.
and those for DZ twins and nontwin sibs, along with
the low risk to more-distant relatives, is highly sugges-
tive of a multigenic mechanism for autism susceptibility,
involving simultaneous defects at multiple loci. How-
ever, the actual number of different contributing loci is
unknown, with the lower limit being three to five genes.
A much larger number could be involved, particularly
if some are small-effect loci. Also, genetic heterogeneity
could add to the number of genes contributing to the
autism phenotype studied here.
One interpretation of the results for D7S630, D7S517,
and D8S264 is that the deletions themselves are autism-
susceptibility alleles and can, in combination with other
as-yet-unidentified loci, cause the disorder. This is a par-
ticularly intriguing possibility for the D7S630 deletion,
because this site, at 98 cM, is close to the regions of
positive linkage reported by several groups (maximum
evidence for linkage is at 103–129 cM) (Ashley-Koch et
al. 1999; Barrett et al. 1999; IMGSAC 2001b). Also,
D7S630 is the closest marker to the proximal breakpoint
for an interstitial 7q inversion reported in a subject with
autism, though this breakpoint has not been precisely
defined (Ashley-Koch et al. 1999). There is a statistically
nonsignificant trend supporting a role for these deletions
in the disease: 10 of 14 affected offspring but only 1 of
4 unaffected offspring had one of the deletions. The fact
that the deletions at the three sites do not perfectly co-
segregate with autism in families is consistent with a mul-
tigenic model in which different combinations of genes
cause the same phenotype and specific susceptibility loci
are not required for autism to occur. Thus, these families
may have a high genetic load of autism high-risk alleles,
and, even in an individual family, the disorder in sibs
could be due to alleles at different subsets of susceptibility
loci. For example, an affected subject without a deletion
(e.g., subject AU09803) (fig. 5) could have a different
complement of autism-susceptibility alleles than his or
her sibling with the deletion. Likewise, subjects with the
deletion but without ASD (e.g., all parents with the de-
letions and some sibs, as in the case of family AU044)
(fig. 5) do not have a sufficient load of susceptibility
alleles to have the disorder. The one deletion that is not
consistent with this model is in family AU025, in which
the shortest D8S264 deletion was only observed in the
unaffected parent and child but not in the affected sibs.
The argument against these deletions being susceptibility
alleles is the way in which these sites were detected. The
prior probability that an autism allele would be detected
by sampling such an extremely small portion of the ge-
nome as was done here is extremely low. Because, in
families with autism, the deletions at D7S630, D7S517,
and D8S264 are rare, if these deletions are true suscep-
tibility alleles, they would account for only a small frac-
tion of the genetic factors contributing to autism in our
families.
A second hypothesis is that alleles at autism-suscep-
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Figure 8 D8S264 region genomic and deletion-allele structures. Deletion-boundary positions given above and beneath the top line (genomic
contig) are based on contig NT_008087.5 (accession number GI:15300158). The region labeled “ambiguous assembly region” potentially has
contig-assembly errors due to repeat sequences (on the basis of the annotation provided for NT_008087.5). Genetic markers with locations in
NT_008087.5 given in parentheses are as follows: 1, rs897445 (62264); 2, rs1824863 (79042); 3, rs922501 (87157); 4, rs899410 (87837); 5,
rs1455638 (257680); 6, rs1382608 (304379); 7, rs958660 (309132); 8, 22257-ATCT (316326); 9, 8152018-CA (329355); 10,D8S264(338805);
11, rs2119237 (344906); and 12, rs936553 (347075). Predicted genes are shown as unblackened arrows, and the known gene MYOM2 is
shown as a hatched arrow.
tibility loci cause deletions and other chromosomal re-
arrangements, possibly by increasing errors in meiosis.
Under this model, the deletions observed here might not
be the cause of autism, but rather the consequence of
autism-susceptibility loci located elsewhere. Also, some
of the events caused by these autism-susceptibility loci
leading to the deletions occurred in previous generations.
Autism would be the result of multiple specific deletions
or mutations of genes critical to neurodevelopment ear-
ly in life, and these critical deletions are not necessarily
those described above. Thus the genes segregating with
autism in the families studied here could be those that
cause the deletions, the critical deletions themselves, or
both. In either case, the genetics of autism would appear
to be complex. The deletions presumably are related to
meiosis rather than mitosis, because there is no evidence
of mosaicism in genotype data generated from white
blood cell DNA (data not shown). However, low levels
of mosaicism might not be detected, so a mitotic mech-
anism cannot be excluded entirely. The deletions do not
appear to be the result of unequal crossing over, because
the breakpoint regions for a given deletion are not con-
sistently homologous as is seen in genomic disorders in
which deletion or duplication breakpoints occur in chro-
mosome-specific low-copy repeats (duplicons) (Lupski
1998). Also, the breakpoints for each deletion do not
share common repeat sequences (e.g., Alu repeats). That
three different deletions were observed for both D7S517
(fig. 4) and D8S264 (fig. 8) indicates that these are in-
dependent events, possibly caused by sequences that pre-
disposed these regions to meiotic errors. Because the dif-
ferent deletion junctions at a given site do not involve
common repeated sequences, the predisposing factor(s)
may involve higher-order chromatin structure. A similar
model has recently been proposed to explain the complex
genetics of panic disorder (Gratacos et al. 2001). A group
of related duplications of a segment on chromosome 15
was observed in affected subjects with panic disorder and
related phenotypes. The deletions are unstable and the
de novo appearance and disappearance of deletions occur
in the same pedigree. The model proposed for panic dis-
order is that this duplication region is predisposed to
duplication/deletion events, because of the presence of
duplicons, and that a mutation or variant in a gene(s)
elsewhere causes an increased frequency of these dupli-
cation events. However, in contrast to autism, the du-
plications appear to involve mitosis errors, because mo-
saicism for the duplications is observed, and duplicons
flank the duplicated sequences.
Evidence supporting an error-pronemeiosismodel for
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autism includes the broad range of deletions, duplica-
tions, and translocations reported in subjects with au-
tism. These include a de novo ∼1-Mb deletion at 15q22-
q23 in a subject with autism, developmental delay, and
mild dysmorphism (Smith et al. 2000), an ∼6-Mb Xp22
deletion in a female subject with autism (Thomas et al.
1999), and a deletion of 17p11.2 in another subjectwith
autism (Vostanis et al. 1994). Also, a 5–6-cM deletion
of chromosome 20 was described in a subject with au-
tism and Hirschsprung disease (HSD [MIM 235730])
(Michaelis et al. 1997). A 4,937-bp deletion at D15S822
was found in families with autism at a slightly higher
frequency than in healthy control subjects (Nurmi et al.
2001). A number of subjects with deletions of 2q37.3
have been reported with autism and facial dysmophism
(Burd et al. 1988; Ghazziuddin and Burnmeister 1999;
Smith et al. 2001). Duplications of 15q11-q13 are ob-
served in a subset of subjects with autism, either as an
interstitial duplication of this region or as supernumer-
ary pseudodicentric marker chromosome containing
one or two extra copies of this region (Gillberg et al.
1991). In subjects with autism, numerous balanced and
complex translocations have been reported, including
several involving 7q. One is a balanced t(1;7)p22; q21
translocation within 1.5 Mb of D7S630 in a subject
diagnosed with both autism and childhood-onsetschi-
zophrenia (SCZD [MIM 181500]) (Yan et al. 2000).
The second is an interstitial inversion of a large seg-
ment of 7q and the breakpoint nearest the centromere
is in the proximity of D7S630 (Ashley-Koch et al. 1999).
Several translocations involving 7q have been reported,
and the chromosome 7 genes that are disrupted by two
of these translocations have been identified (Vincent et
al. 2000; Sultana et al., in press). Numerous translo-
cations involving other chromosomes have been re-
ported in subjects with autism and include unbalanced
translocations with partial chromosomal monosomy
(Vostanis et al. 1994) and balanced translocations with
no obvious deleted segments. However, there is no ob-
vious cluster of breakpoints at any specific chromo-
somal location. There is one report of a subject with
a xeroderma pigmentosum group C (XPC [MIM
278720]) mutation who has autism (Khan et al. 1998).
Whether both disorders occurred in this subject by
chance or because of the DNA repair defect caused by
the mutation in the XPC gene is unknown. It is diffi-
cult to determine whether the spectrum of genomic ab-
normalities seen in autism is unique, in part because
ascertainment of these abnormalities is not systemat-
ic. Also, deletions the size detected here are not ob-
servable cytogenetically and have not been routinely
sought in other disorders. However, autism does appear
to be unique, in that there is no other disorder associat-
ed with cytogenetic abnormalities and deletions scat-
tered throughout the genome.
More direct evidence that meiosis is altered in sub-
jects with autism comes from the increased rate of re-
combination for a portion of chromosome 7 (Ashley-
Koch et al. 1999) and for 15q11-q13 (Bass et al. 1999)
seen in autism relative to control families. Additional
work is needed to confirm the increased recombination
rate in families with autism and to determine whether
regions other than 7q and 15q11-q13 are involved. In-
creased recombination rates have not been observed as
part of the phenotype of other inherited disorders, nor
has there been a gene defect identified in a human dis-
ease leading to errors in meiosis.
The D8S272 deletion is a polymorphism allele present
in control subjects at a frequency of 0.026–0.104 (table
4). Although other polymorphic in/del alleles have been
reported, the D8S272 site is unique in terms of the size
of the segment deleted. Other large in/del polymor-
phisms include D15S63, where a 28-kb deletion allele
was characterized (Silverstein et al. 2001). This site is
in the 15q11-q13 PWS/AS region, which is known to
be highly unstable. Another large in/del is on chromo-
some 15, 25 kb downstream of the PML gene (MIM
102578) (Goy et al. 1995; Gilles et al. 2000). This poly-
morphic system has five common alleles that comprise
different numbers of 30-kb tandem repeat sequences.
The difference between the smallest and largest allele is
∼140 kb. Recently, a 33,048-bp insertion allele poly-
morphism was detected in the process of determining
the DNA sequence of chromosome 20 (Deloukas et al.
2001). Numerous large deletions and insertions have
been characterized as causing different genetic diseases,
affecting either single or multiple genes. However, these
disease-related duplications and deletions are not poly-
morphisms. Likewise, large deletions are common in
tumors, although, again, these are acquired as somatic
cell events and are not polymorphisms. At present, it is
not clear how frequently large deletions comparable to
the D8S272 site occur as non–disease-related polymor-
phism alleles. The detection of the D8S272 by sampling
only a small fraction of the genome suggests that large-
deletion alleles may be relatively common. Methods de-
signed specifically to detect polymorphic sites—such as
RFLP analysis, screening short and long tandem repeats
for polymorphisms, and detection of SNPs and in/del
sites either by direct DNA sequencing or by database
sequence comparisons—will potentially miss the type of
deletion allele observed here. Further work is needed to
determine how common these sites are, by use of meth-
ods designed specifically to detect large-deletion alleles.
The frequency of the D8S272 deletion allele varied
significantly between the young and elderly control
groups and between the control groups and the au-
tism sample, suggesting that the two alleles could have
different phenotypic effects. However, because the sam-
pling schemes were different for each of the control
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groups and the subjects with autism, a more likely ex-
planation of these results is that the deletion allele fre-
quency varies substantially in different populations.
The physiologic consequences, if any, of the deletion
alleles detected here are difficult to predict. No gene of
known function was affected by the deletions. A number
of GenScan-predicted genes are in the deletions. One of
these, in the D8S264 deletion region, matches a known
EST that appears to be the product of a spliced message
and thus is almost certainly a real expressed gene. The
predicted gene in the center of the D8S272 region also
matches a known EST. This EST was expressed from a
promoter vector inserted randomly throughout the ge-
nome to generate a RAGE cDNA library for identifica-
tion of novel undetected genes (Harrington et al. 2001)
and thus might not be a real expressed gene. However,
the EST sequence, when compared with the genomic se-
quence, is consistent with intron-exon splicing. Analysis
of novel sequences from RAGE libraries suggests that
155% are actually expressed genes. Although, at the pre-
sent time, it is unknown whether the other predicted
genes are actually expressed, a recent evaluation of novel
GenScan-predicted genes from chromosome 22 suggests
that at least 27% of the predicted genes are expressed
(Das et al. 2001).
The deletions encountered in the autism linkage
study were unexpected, since similar findings have not
been reported for other large linkage studies. Thus, it
is not possible to evaluate the statistical signifi-
cance of the deletion frequencies detected here. Since
large-deletion alleles are not routinely detected by other
methods for polymorphism discovery, large-dele-
tion–allele polymorphisms may be an underappreciated
class of genetic variability in humans. Deletions of the
size reported here potentially could contribute to human
phenotype variability, either by deleting one or more
genes or by influencing the expression of neighboring
genes. Thus, identification and characterization of large-
deletion–allele polymorphisms may be important for
understanding the influence of genetic variability on
normal and disease-related phenotypes.
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VCFS [MIM 192430], MYOM2 [MIM 603509], LOAD
[MIM 104300], HSD [MIM 235730], SCZD [MIM181500],
XPC [MIM 278720], and PML [MIM 102578])
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